Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Information, Expiry & Status of FDA Orange Book Patents covering Desvenlafaxine Succinate

Client Email

Product

Desvenlafaxine Succinate
US Patents

lebsa-m-2024-10-21

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Desvenlafaxine Succinate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

49 API Suppliers, 27 USDMF, 14 EU WC, 11 KDMF, 15 NDC API, 30 Listed Suppliers, $ API Reference Price

49 API Suppliers
27 USDMF
14 EU WC
11 KDMF
15 NDC API
30 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports

API Reference Price
API Exports
API Imports

FINISHED DOSAGE FORMULATIONS

102 FDF Dossiers, 34 FDA Orange Book, 6 Europe, 19 Canada, 14 Australia, 12 South Africa, 17 Listed Dossiers

102 FDF Dossiers
34 FDA Orange Book
6 Europe
19 Canada
14 Australia
12 South Africa
17 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - EQ 100MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 25MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 50MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 100MG BASE
TABLET, EXTENDED RELEASE;ORAL - EQ 25MG BASE
TABLET, EXTENDED RELEASE;ORAL - EQ 50MG BASE

RELATED EXCIPIENT COMPANIES

1 Minakem, 2 SPI Pharma, 2 Seqens, 4 DKSH, 1 Jai Radhe Sales, 5 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 7 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 BASF, 1 Clariant, 10 Corel Pharma Chem, 2 DFE Pharma, 2 Finar, 7 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 17 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 8 Microlex e.U, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 1 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 9 Roquette, 7 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 9 Sigachi Industries, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

51 Coating Systems & Additives, 30 Fillers, Diluents & Binders, 28 Controlled & Modified Release, 23 Lubricants & Glidants, 20 Thickeners and Stabilizers, 15 Direct Compression, 15 Topical, 13 Film Formers & Plasticizers, 11 Co-Processed Excipients, 10 Disintegrants & Superdisintegrants, 8 Granulation, 8 Solubilizers, 6 API Stability Enhancers, 5 Parenteral, 5 Empty Capsules, 5 Coloring Agents, 5 Emulsifying Agents, 5 Chewable & Orodispersible Aids, 4 Vegetarian Capsules, 4 Taste Masking, 2 Rheology Modifiers

51 Coating Systems & Additives
30 Fillers, Diluents & Binders
28 Controlled & Modified Release
23 Lubricants & Glidants
20 Thickeners and Stabilizers
15 Direct Compression
15 Topical
13 Film Formers & Plasticizers
11 Co-Processed Excipients
10 Disintegrants & Superdisintegrants
8 Granulation
8 Solubilizers
6 API Stability Enhancers
5 Parenteral
5 Empty Capsules
5 Coloring Agents
5 Emulsifying Agents
5 Chewable & Orodispersible Aids
4 Vegetarian Capsules
4 Taste Masking
2 Rheology Modifiers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 16 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
16 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 9 Finished Drug Prices, 6 Annual Reports

1 US Medicaid Prescriptions
9 Finished Drug Prices
6 Annual Reports

MARKET PLACE

10 APIs, 1 FDF Dossiers

10 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 US Patents, 2 Health Canada Patents

3 US Patents
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 Others

4 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 725 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

3 All

01 3PF PRISM CV

filter Patent Number Reset all filters

3 All

01 38269040

filter API Patent Reset all filters

3 All

01 3Y

filter FDF Patent Reset all filters

3 All

01 3Blank

filter Expiration Date Reset all filters

3 All

01 32027-07-05

US Patents
Health Canada Patents

Product Main Page

01

PF PRISM CV

DESVENLAFAXINE SUCCINATE

Aquaexpo 2024

Not Confirmed

PF PRISM CV

Aquaexpo 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-07-05

DESVENLAFAXINE SUCCINATE

US Patent Number : 8269040

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 21992

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-07-05

Portfolio PDF

Product Web Link

Digital Content

02

PF PRISM CV

DESVENLAFAXINE SUCCINATE

Aquaexpo 2024

Not Confirmed

PF PRISM CV

Aquaexpo 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-07-05

DESVENLAFAXINE SUCCINATE

US Patent Number : 8269040

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 21992

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-07-05

Portfolio PDF

Product Web Link

Digital Content

03

PF PRISM CV

DESVENLAFAXINE SUCCINATE

Aquaexpo 2024

Not Confirmed

PF PRISM CV

Aquaexpo 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-07-05

DESVENLAFAXINE SUCCINATE

US Patent Number : 8269040

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 21992

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-07-05

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?